National Cancer Institute; Notice of Closed Meetings, 4319 [2016-01367]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 16 / Tuesday, January 26, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus SEP–4 R03 & R21.
Date: March 3–4, 2016.
Time: 6:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center; Montgomery County
Conference Center Facility; 5701 Marinelli
Road; North Bethesda, MD 20852.
Contact Person: Clifford W. Schweinfest,
Ph.D.; Scientific Review Officer; Special
Review Branch; Division of Extramural
Activities; National Cancer Institute; 9609
Medical Center Drive, Room 7W108;
Bethesda, MD 20892–9750; 240–276–6343;
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R13
Conference Grant Review.
Date: March 2, 2016.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove; 9609 Medical Center Drive; Room
7W556; Rockville, MD 20850; (Telephone
Conference Call).
Contact Person: Bratin K. Saha, Ph.D.;
Scientific Review Officer; Program
Coordination and Referral Branch; Division
Of Extramural Activities; National Cancer
Institute; 9609 Medical Center Drive, Room
7W556; Bethesda, MD 20892–9750; 240–276–
6411; sahab@mail.nih.gov
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Molecular Analysis Technologies for Cancer
Research.
Date: March 8, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City;
1250 South Hayes Street; Arlington, VA
22202.
Contact Person: Gerard Lacourciere, Ph.D.;
Scientific Review Officer; Research
VerDate Sep<11>2014
21:57 Jan 25, 2016
Jkt 238001
Technology and Contract Review Branch;
Division of Extramural Activities; National
Cancer Institute, NIH; 9609 Medical Center
Drive, 7W248; Rockville, MD 20850; 240–
276–5457; gerard.lacourciere@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI
Provocative Questions—6.
Date: March 10, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove; 9609 Medical Center Drive; Room
7W032; Rockville, MD 20850 (Telephone
Conference Call)
Contact Person: Thomas A. Winters, Ph.D.;
Scientific Review Officer; Special Review
Branch; Division of Extramural Activities;
National Cancer Institute, NIH; 9609 Medical
Center Drive, Room 7W412; Rockville, MD
20850; 240–276–6386; twinters@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel Omnibus
SEP–11B.
Date: March 17, 2016.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove; 9609 Medical Center Drive; Room
6W032; Rockville, MD 20850; (Telephone
Conference Call).
Contact Person: Majed M. Hamawy, Ph.D.;
Scientific Review Officer; Research Programs
Review Branch; Division of Extramural
Activities; National Cancer Institute, NIH;
9609 Medical Center Drive, Room 7W120;
Bethesda, MD 20892–8328; 240–276–6457;
mh101v@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel Omnibus
SEP–16 R03 & R21.
Date: March 31, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove; 9609 Medical Center Drive; Room
7W554; Rockville, MD 20850; (Telephone
Conference Call).
Contact Person: Christopher L. Hatch,
Ph.D.; Chief Program Coordination & Referral
Branch; Division of Extramural Activities;
National Cancer Institute, NIH; 9609 Medical
Center Drive, Room 7W554; Bethesda, MD
20892–8328; 240–276–6457 ch29v@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Questions Review—PQ 9.
Date: April 5, 2016.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove; 9609 Medical Center Drive; Room
7W126 Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Caron A. Lyman, Ph.D.;
Chief, Scientific Review Officer; Research
Programs Review Branch; Division of
Extramural Activities; National Cancer
Institute, NIH; 9609 Medical Center Drive,
Room 7W126; Bethesda, MD 20892–8328;
240–276–6348; lymanc@nih.gov.
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
4319
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Questions Review—PQ 4.
Date: April 6, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove; 9609 Medical Center Drive; Room
7W126; Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Caron A. Lyman, Ph.D.;
Chief, Scientific Review Officer Research
Programs Review Branch; Division of
Extramural Activities; National Cancer
Institute, NIH; 9609 Medical Center Drive,
Room 7W126; Bethesda, MD 20892–8328;
240–276–6348; lymanc@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 20, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–01367 Filed 1–25–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel; R01/R21/
K99/K01 Conflicts.
Date: February 25, 2016.
Time: 12:00 p.m. to 4:00 p.m.
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 81, Number 16 (Tuesday, January 26, 2016)]
[Notices]
[Page 4319]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01367]
[[Page 4319]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus SEP-4 R03 & R21.
Date: March 3-4, 2016.
Time: 6:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center;
Montgomery County Conference Center Facility; 5701 Marinelli Road;
North Bethesda, MD 20852.
Contact Person: Clifford W. Schweinfest, Ph.D.; Scientific
Review Officer; Special Review Branch; Division of Extramural
Activities; National Cancer Institute; 9609 Medical Center Drive,
Room 7W108; Bethesda, MD 20892-9750; 240-276-6343;
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R13 Conference Grant Review.
Date: March 2, 2016.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove; 9609 Medical
Center Drive; Room 7W556; Rockville, MD 20850; (Telephone Conference
Call).
Contact Person: Bratin K. Saha, Ph.D.; Scientific Review
Officer; Program Coordination and Referral Branch; Division Of
Extramural Activities; National Cancer Institute; 9609 Medical
Center Drive, Room 7W556; Bethesda, MD 20892-9750; 240-276-6411;
sahab@mail.nih.gov
Name of Committee: National Cancer Institute Special Emphasis
Panel; Innovative Molecular Analysis Technologies for Cancer
Research.
Date: March 8, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz-Carlton Hotel at Pentagon City; 1250 South Hayes
Street; Arlington, VA 22202.
Contact Person: Gerard Lacourciere, Ph.D.; Scientific Review
Officer; Research Technology and Contract Review Branch; Division of
Extramural Activities; National Cancer Institute, NIH; 9609 Medical
Center Drive, 7W248; Rockville, MD 20850; 240-276-5457;
gerard.lacourciere@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel NCI Provocative Questions--6.
Date: March 10, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove; 9609 Medical
Center Drive; Room 7W032; Rockville, MD 20850 (Telephone Conference
Call)
Contact Person: Thomas A. Winters, Ph.D.; Scientific Review
Officer; Special Review Branch; Division of Extramural Activities;
National Cancer Institute, NIH; 9609 Medical Center Drive, Room
7W412; Rockville, MD 20850; 240-276-6386; twinters@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel Omnibus SEP-11B.
Date: March 17, 2016.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove; 9609 Medical
Center Drive; Room 6W032; Rockville, MD 20850; (Telephone Conference
Call).
Contact Person: Majed M. Hamawy, Ph.D.; Scientific Review
Officer; Research Programs Review Branch; Division of Extramural
Activities; National Cancer Institute, NIH; 9609 Medical Center
Drive, Room 7W120; Bethesda, MD 20892-8328; 240-276-6457;
mh101v@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel Omnibus SEP-16 R03 & R21.
Date: March 31, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove; 9609 Medical
Center Drive; Room 7W554; Rockville, MD 20850; (Telephone Conference
Call).
Contact Person: Christopher L. Hatch, Ph.D.; Chief Program
Coordination & Referral Branch; Division of Extramural Activities;
National Cancer Institute, NIH; 9609 Medical Center Drive, Room
7W554; Bethesda, MD 20892-8328; 240-276-6457 ch29v@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Provocative Questions Review--PQ 9.
Date: April 5, 2016.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove; 9609 Medical
Center Drive; Room 7W126 Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Caron A. Lyman, Ph.D.; Chief, Scientific Review
Officer; Research Programs Review Branch; Division of Extramural
Activities; National Cancer Institute, NIH; 9609 Medical Center
Drive, Room 7W126; Bethesda, MD 20892-8328; 240-276-6348;
lymanc@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Provocative Questions Review--PQ 4.
Date: April 6, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove; 9609 Medical
Center Drive; Room 7W126; Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Caron A. Lyman, Ph.D.; Chief, Scientific Review
Officer Research Programs Review Branch; Division of Extramural
Activities; National Cancer Institute, NIH; 9609 Medical Center
Drive, Room 7W126; Bethesda, MD 20892-8328; 240-276-6348;
lymanc@nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: January 20, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-01367 Filed 1-25-16; 8:45 am]
BILLING CODE 4140-01-P
